Document is current
Any future updates will be listed below
-
Authors
Johnston, Midori
Dissanayake-Perera, Schan
Collins, James J. https://orcid.org/0000-0002-5560-8246
Stevens, Molly M.
Dincer, Can https://orcid.org/0000-0003-3301-1198
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (13GW0493, 13GW0493)
Royal Academy of Engineering (CiET2021\94)
- License Information
-
More Information
Article History
Received: 10 June 2024
Accepted: 6 August 2025
First Online: 2 October 2025
Competing interests
: J.J.C. was a co-founder and board member of Sherlock Biosciences, which was focused on developing CRISPR-based diagnostics and recently acquired by Orasure. M.M.S. has invested in, consults for (or was on scientific advisory boards or boards of directors) and conducts sponsored research funded by companies related to the biomaterials field; and has filed patent applications related to nanocatalysts for biosensing. M.M.S. and S.D-P. have filed a patent application (patent no. US20250092459 - US only) on nanozyme-catalysed detection. M.J. and C.D. declare no competing interests.
